Effect of transurethral resection on serum free/total prostate-specific antigen levels in patients with benign prostatic hyperplasia - the establishment of appropriate reference ranges for concentrations and ratios

By Cetinkaya M.   Ulusoy E.   Aki T.   Kosan M.   Kundak c.   Aydos M.M.   Gokkaya S.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 118-120

Elsevier

Access to resources Recommend Favorite

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting

By Keetch D.W.   Andriole G.L.   Ratliff T.L.   Catalona W.J.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

''BPSA,'' a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia1

By Mikolajczyk S.D.   Millar L.S.   Wang T.J.   Rittenhouse H.G.   Wolfert R.L.   Marks L.S.   Song W.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia

By Mochtar C.A.   Kiemeney L.A.L.M.   van Riemsdijk M.M.   Barnett G.S.   Laguna M.P.   Debruyne F.M.J.   de la Rosette J.J.M.C.H.  

European Urology, Vol. 44, Iss. 6, 2003-12 ,pp. : 695-700

Elsevier

Access to resources Recommend Favorite

Age-specific reference ranges for prostate specific antigen-total and free in patients with prostatitis symptoms and patients at risk

By Battikhi M.   Hussein I.  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 559-564

Springer Publishing Company

Access to resources Recommend Favorite